The two biggest biopharma licensing and investment events, BIO and RESI, respectively, will be in Boston mid-June. BIO will feature thousands of large pharma delegates seeking licensing candidates while RESI will have over 400 seed through series B investors and pharma external innovation scouts. If you’re targeting a pharma deal in the short or long term, you should know which pharmas are best fits for you, and you should be starting conversations with them already. This applies equally if you’re seeking funding or out-licensing. Earlier stage companies will want to court the early innovation scouts at RESI while later stage biotechs will want to target the BD&L scouts at BIO.
To help you determine which pharma partners are optimally aligned with your company and submit your non-confidential deck or proposal in advance of BIO and RESI, we’ve provided the LSN Pharma Directory. This guide lists the business development/licensing/partnering pages for the top pharmas and lets you instantly see their licensing goals. Get the conversation started (for follow-up at BIO and RESI) by leveraging the submission portals contained in the Directory. The hundreds of investors attending BIO will want to see that you have a solid exit plan and have a good sense of the competitive landscape. Check out the LSN Pharma Directory for free now!
| Check Out the LSN Pharma Directory for Free now! |
Next Phase Newsletter 
Leave a comment